Schneidawind D - Search Results

1

Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations.

Secker KA, Bruns L, Keppeler H, Jeong J, Hentrich T, Schulze-Hentrich JM, Mankel B, Fend F, Schneidawind D, Schneidawind C. Secker KA, et al. Among authors: schneidawind c, schneidawind d. Cancers (Basel). 2020 Jun 7;12(6):1487. doi: 10.3390/cancers12061487. Cancers (Basel). 2020. PMID: 32517300 Free PMC article.

2

Allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia and pulmonary mucormycosis.

Schneidawind D, Nann D, Vogel W, Faul C, Fend F, Horger M, Kanz L, Bethge W. Schneidawind D, et al. Transpl Infect Dis. 2012 Dec;14(6):E166-72. doi: 10.1111/tid.12019. Epub 2012 Oct 17. Transpl Infect Dis. 2012. PMID: 23075207

3

MLL leukemia induction by genome editing of human CD34+ hematopoietic cells.

Buechele C, Breese EH, Schneidawind D, Lin CH, Jeong J, Duque-Afonso J, Wong SH, Smith KS, Negrin RS, Porteus M, Cleary ML. Buechele C, et al. Among authors: schneidawind d. Blood. 2015 Oct 1;126(14):1683-94. doi: 10.1182/blood-2015-05-646398. Epub 2015 Aug 26. Blood. 2015. PMID: 26311362 Free PMC article.

4

Follow-up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantation.

Schneidawind C, Duerr-Stoerzer S, Faul C, Kanz L, Weisel K, Bethge W, Schneidawind D. Schneidawind C, et al. Among authors: schneidawind d. Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12994. Epub 2017 May 26. Clin Transplant. 2017. PMID: 28470884

5

MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing.

Schneidawind C, Jeong J, Schneidawind D, Kim IS, Duque-Afonso J, Wong SHK, Iwasaki M, Breese EH, Zehnder JL, Porteus M, Cleary ML. Schneidawind C, et al. Among authors: schneidawind d. Blood Adv. 2018 Apr 24;2(8):832-845. doi: 10.1182/bloodadvances.2017013748. Blood Adv. 2018. PMID: 29650777 Free PMC article.

6

Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia.

Schneidawind C, Hagmaier V, Faul C, Kanz L, Bethge W, Schneidawind D. Schneidawind C, et al. Among authors: schneidawind d. Ann Hematol. 2018 Dec;97(12):2491-2500. doi: 10.1007/s00277-018-3454-y. Epub 2018 Jul 31. Ann Hematol. 2018. PMID: 30066039 Clinical Trial.

7

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia.

Schmid H, Schneidawind C, Jahnke S, Kettemann F, Secker KA, Duerr-Stoerzer S, Keppeler H, Kanz L, Savage PB, Schneidawind D. Schmid H, et al. Among authors: schneidawind c, schneidawind d. Front Immunol. 2018 Aug 6;9:1817. doi: 10.3389/fimmu.2018.01817. eCollection 2018. Front Immunol. 2018. PMID: 30127790 Free PMC article.

8

G-CSF administration prior to donor lymphocyte apheresis promotes anti-leukaemic effects in allogeneic HCT patients.

Schneidawind C, Jahnke S, Schober-Melms I, Schumm M, Handgretinger R, Faul C, Kanz L, Bethge W, Schneidawind D. Schneidawind C, et al. Among authors: schneidawind d. Br J Haematol. 2019 Jul;186(1):60-71. doi: 10.1111/bjh.15881. Epub 2019 Mar 27. Br J Haematol. 2019. PMID: 30916396 Free article.

9

Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote ex vivo Lysis of Leukemic Blasts in a CD1d-Dependent Manner.

Jahnke S, Schmid H, Secker KA, Einhaus J, Duerr-Stoerzer S, Keppeler H, Schober-Melms I, Baur R, Schumm M, Handgretinger R, Bethge W, Kanz L, Schneidawind C, Schneidawind D. Jahnke S, et al. Among authors: schneidawind c, schneidawind d. Front Immunol. 2019 Jul 9;10:1542. doi: 10.3389/fimmu.2019.01542. eCollection 2019. Front Immunol. 2019. PMID: 31354710 Free PMC article.

10

Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9.

Secker KA, Keppeler H, Duerr-Stoerzer S, Schmid H, Schneidawind D, Hentrich T, Schulze-Hentrich JM, Mankel B, Fend F, Schneidawind C. Secker KA, et al. Among authors: schneidawind c, schneidawind d. Oncogene. 2019 Nov;38(46):7181-7195. doi: 10.1038/s41388-019-0937-9. Epub 2019 Aug 15. Oncogene. 2019. PMID: 31417187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page